Trimurthi Drugs & Pharmaceuticals Limited announced unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company announced net sales or income from operations of INR 11.453 million compared to INR 44.268 million a year ago. Profit from ordinary activities before tax was INR 1.961 million compared to INR 2.205 million a year ago. Net profit was INR 1.138 million or INR 0.17 per basic and diluted share for before extraordinary items compared to INR 1.675 million or INR 0.25 per basic and diluted share for before extraordinary items a year ago.

For the nine months, the company announced net sales or income from operations of INR 41.081 million compared to INR 89.552 million a year ago. Profit from ordinary activities before tax was INR 5.242 million compared to INR 5.633 million a year ago. Net profit was INR 3.544 million or INR 0.53 per basic and diluted share for before extraordinary items compared to INR 4.118 million or INR 0.61 per basic and diluted share for before extraordinary items a year ago.